| Literature DB >> 29029109 |
Hugo Katus1, André Ziegler2, Okan Ekinci3,4, Evangelos Giannitsis1, Wendy Gattis Stough5, Stephan Achenbach6, Stefan Blankenberg7, Martina Brueckmann8,9, Paul Collinson10,11, Dorin Comaniciu3, Filippo Crea12, Wilfried Dinh13,14, Grégory Ducrocq15, Frank A Flachskampf16, Keith A A Fox17, Matthias G Friedrich18,19, Kathy A Hebert20, Anders Himmelmann21, Mark Hlatky22, Dominik Lautsch23, Bertil Lindahl16, Daniel Lindholm24, Nicholas L Mills25, Giorgio Minotti26, Martin Möckel27, Torbjørn Omland28, Véronique Semjonow29.
Abstract
The diagnostic evaluation of acute chest pain has been augmented in recent years by advances in the sensitivity and precision of cardiac troponin assays, new biomarkers, improvements in imaging modalities, and release of new clinical decision algorithms. This progress has enabled physicians to diagnose or rule-out acute myocardial infarction earlier after the initial patient presentation, usually in emergency department settings, which may facilitate prompt initiation of evidence-based treatments, investigation of alternative diagnoses for chest pain, or discharge, and permit better utilization of healthcare resources. A non-trivial proportion of patients fall in an indeterminate category according to rule-out algorithms, and minimal evidence-based guidance exists for the optimal evaluation, monitoring, and treatment of these patients. The Cardiovascular Round Table of the ESC proposes approaches for the optimal application of early strategies in clinical practice to improve patient care following the review of recent advances in the early diagnosis of acute coronary syndrome. The following specific 'indeterminate' patient categories were considered: (i) patients with symptoms and high-sensitivity cardiac troponin <99th percentile; (ii) patients with symptoms and high-sensitivity troponin <99th percentile but above the limit of detection; (iii) patients with symptoms and high-sensitivity troponin >99th percentile but without dynamic change; and (iv) patients with symptoms and high-sensitivity troponin >99th percentile and dynamic change but without coronary plaque rupture/erosion/dissection. Definitive evidence is currently lacking to manage these patients whose early diagnosis is 'indeterminate' and these areas of uncertainty should be assigned a high priority for research. Published on behalf of the European Society of Cardiology. All rights reserved.Entities:
Keywords: Acute coronary syndrome; Troponin
Mesh:
Substances:
Year: 2017 PMID: 29029109 DOI: 10.1093/eurheartj/ehx492
Source DB: PubMed Journal: Eur Heart J ISSN: 0195-668X Impact factor: 29.983